• AI-Driven Prognostic Signature Enhances HCC Risk Stratificat

  2026-04-19

  This study introduces a consensus artificial intelligence-derived prognostic signature (CAIPS) that integrates ten machine learning algorithms across large multi-center hepatocellular carcinoma (HCC) cohorts. The results demonstrate CAIPS outperforms traditional clinical markers and existing signatures, with significant implications for precision oncology and therapeutic selection.

• Clozapine in Schizophrenia Research: Workflow & Innovation

  2026-04-18

  Clozapine’s unique receptor profile and ERK1/2 pathway activation empower advanced schizophrenia research, especially for treatment-resistant models. This article delivers protocol optimization, troubleshooting, and practical insights for leveraging APExBIO’s Clozapine in translational neuroscience.

• 10 mM dNTP Mixture: Workflow Optimization for DNA Synthesis

  2026-04-17

  Unlock high-fidelity DNA synthesis and streamlined nanoparticle research with the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. This guide translates cutting-edge findings on nanoparticle trafficking into actionable protocol enhancements, troubleshooting tips, and advanced applications for molecular biology labs.

• Cyclo (-RGDfC): Optimizing Integrin αvβ3 Targeting in Cancer

  2026-04-16

  Cyclo (-RGDfC) from APExBIO delivers precise integrin αvβ3 targeting for robust cell adhesion, migration, and tumor targeting applications. This article bridges bench protocols and troubleshooting strategies, streamlining your angiogenesis and cancer research workflows with actionable guidelines.

• Epigenetic Regulation of PDK1 Drives TKI Resistance in Cance

  2026-04-15

  This study uncovers how epigenetic modifications via KDM3A and METTL16 elevate PDK1 expression, promoting resistance to EGFR tyrosine kinase inhibitors and advancing tumorigenesis. The findings clarify molecular mechanisms underlying TKI resistance and suggest actionable targets for improving therapy in EGFR-mutant cancers.

• Shufeng Xingbi Therapy Modulates Immunity and Microbiota in

  2026-04-14

  This study investigates the effects of Shufeng Xingbi Therapy (SFXBT) on Th1/Th2 immune balance and gut microbiota in a rat model of allergic rhinitis. The findings highlight SFXBT’s ability to alleviate inflammatory symptoms by regulating key immune markers and altering intestinal flora, offering mechanistic insights for future translational research.

• Preclinical Insights: Anlotinib Hydrochloride as a Selective

  2026-04-13

  This article reviews the seminal work characterizing anlotinib hydrochloride as a highly potent and selective VEGFR2 inhibitor with robust anti-angiogenic activity. The findings highlight its superior pharmacological profile against endothelial cell functions central to tumor angiogenesis, laying a preclinical foundation for translational research in cancer therapy.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays

  2026-04-12

  Leverage the next-generation Firefly Luciferase mRNA with Cap 1 structure for unmatched reporter sensitivity, stability, and translation efficiency. Discover actionable protocols, experimental insights, and troubleshooting strategies that set this bioluminescent reporter apart for gene regulation and in vivo imaging applications.

• (-)-JQ1 (SKU A8181): Raising Control Standards in BET Inhibi

  2026-04-12

  This article delivers an evidence-driven roadmap for deploying (-)-JQ1 (SKU A8181) as the gold-standard inactive control in BET bromodomain inhibitor research. Through real-world laboratory scenarios, it demonstrates how (-)-JQ1 ensures assay specificity, reproducibility, and robust data interpretation in BRD4-dependent workflows. Researchers gain actionable insights into protocol optimization and product selection, grounded in peer-reviewed findings and practical expertise.

• PD 0332991 (Palbociclib) HCl: Applied Workflows for Tumor Mo

  2026-04-11

  PD 0332991 (Palbociclib) HCl delivers selective and reproducible cell cycle arrest in Rb-positive tumor models, making it a pivotal tool for high-fidelity drug testing in advanced cancer assembloid systems. This guide translates recent innovations and troubleshooting strategies into actionable protocols, empowering researchers to optimize the use of this CDK4/6 inhibitor in complex in vitro and in vivo studies.

• Artesunate: Optimizing Artemisinin Derivatives for Cancer Re

  2026-04-11

  Artesunate, a semi-synthetic artemisinin derivative, unlocks new precision in cancer drug evaluation through potent ferroptosis induction and AKT/mTOR pathway inhibition. Explore advanced experimental workflows, troubleshooting strategies, and actionable insights that set Artesunate apart in small cell lung carcinoma and esophageal squamous cell carcinoma research.

• Halazone: Antimicrobial Sulfonamide for Water Disinfection

  2026-04-10

  Halazone uniquely bridges robust waterborne pathogen control with cutting-edge neurophysiological research, thanks to its dual-action as an oxidative bactericidal agent and neuronal sodium channel modulator. This guide delivers actionable workflows, advanced use-cases, and troubleshooting insights for maximizing Halazone’s impact in both microbiological and neurophysiological applications. Discover how APExBIO’s high-purity Halazone sets the standard for reliability and experimental reproducibility.

• Sulfo-Cy3 Azide: Photostable Dye for Click Chemistry Labe...

  2026-04-09

  Sulfo-Cy3 azide, a sulfonated hydrophilic fluorescent dye, empowers researchers to perform robust, high-sensitivity Click Chemistry fluorescent labeling in aqueous environments. Its exceptional water solubility, photostability, and minimized fluorescence quenching make it the reagent of choice for labeling proteins, alkyne-modified oligonucleotides, and intact biological samples, even in challenging neurodevelopmental studies.

• Reactive Oxygen Species (ROS) Assay Kit (DHE): Precision ...

  2026-04-08

  The Reactive Oxygen Species (ROS) Assay Kit (DHE) enables sensitive, quantitative ROS detection in living cells. By leveraging the dihydroethidium (DHE) probe, this APExBIO kit provides robust intracellular superoxide measurement critical for oxidative stress and apoptosis research. It sets benchmarks for accuracy, workflow integration, and reproducibility in redox biology.

• Bovine Insulin: Precision Growth Factor for Cell Culture ...

  2026-04-08

  Bovine insulin offers unmatched reliability as a peptide hormone for cell culture, driving robust cell proliferation and metabolic modeling. Its high purity and unique solubility profile empower experimentalists to achieve consistent, reproducible results in advanced applications—especially where metabolic regulation and diabetes research intersect. Discover how APExBIO’s Bovine Insulin streamlines workflows and resolves common assay bottlenecks.

450 records 21/30 page Previous Next First page 上5页 2122232425 下5页 Last page